Positron Emission Tomography/Computed Tomography in Thyroid Cancer.

Chandrasekhar Bal, Dhritiman Chakraborty, Dikhra Khan

Journal: PET clinics 2022;17(2):265-283

PMID: 35256297

Full Text on Elsevier Science View on PubMed

Abstract

Fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG PET/CT) plays an important role in the management of thyroid malignancies. Incidentally found FDG avid nodule needs further workup to rule out its malignant potential. 18F-FDG PET/CT has a proven role in detecting recurrent disease or the metastatic workup of the thyroglobulin elevated negative radioiodine scan (TENIS) scenario. In managing histologically aggressive carcinoma of the thyroid, 18F-FDG PET/CT has a proven role. The theranostic potential has been explored with PET/CT using 68Ga-SSA, 68Ga-PSMA,68Ga-FAPI, and 68Ga-DOTA-RGD. The 124I PET/CT role is just being investigated for better spatial resolution and helps in dosimetry.

Address: Department of Nuclear Medicine, AIIMS, New Delhi 110029, India. Electronic address: [email protected].; Department of Nuclear & Experimental Medical Sciences, Institute of Post Graduate Medical Education and Research/SSKM Hospital, Kolkata, West Bengal, India.; Department of Nuclear Medicine, AIIMS, New Delhi 110029, India.

DOI: 10.1016/j.cpet.2021.12.004